Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM1: Emergency Use Authorization of Remdesivir for Patients With Confirmed or Suspected COVID-19

In this concise presentation, Dr. Vikramjit Mukherjee discusses the indications, dosing guidelines, and special considerations outlined in the FDA emergency use authorization of remdesivir for treatment of COVID-19.
Vikramjit Mukherjee, MD
Released: May 22, 2020

Information on this Educational Activity

Faculty

Vikramjit Mukherjee, MD

Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York

Vikramjit Mukherjee, MD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

CCO expert slideset of key COVID-19 data from IDWeek 2020, including new findings on transmission, progression, clinical outcomes, treatment, and more

Rajesh T. Gandhi, MD Released: November 5, 2020

Dr. Jens Lundgren discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19 from CCO

Jens D. Lundgren, MD, DMSc Released: October 16, 2020

John Pagel, MD, PhD discusses incorporating telemedicine and other strategies into the care plan for patients with CLL during COVID-19

John Pagel Headshot John Pagel, MD, PhD Released: July 13, 2020

Living slideset on optimal management of CLL during the COVID-19 pandemic will be continually up-to-date as the situation evolves and new data emerge

Jacqueline Barrientos, MD, MS Nicole Lamanna, MD John Pagel Headshot John Pagel, MD, PhD person default Jacob D. Soumerai, MD Released: July 2, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue